-1st line chemotherapy and contribution of bevacizumab - Impact of second-line chemotherapy in unselected patients -Impact of Nintedanib in 2nd line...

Date 08 July 2015
Event ESMO Preceptorship on NSCLC 2015
Session Session 3 - 1st line chemotherapy and contribution of bevacizumab
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Presenter Wilfried Eberhardt
Authors W.E. Eberhardt
  • Department Of Medical Oncology, West German Cancer Center, 45122 - Essen/DE